Email Alerts
RSS
Volume 38 Issue 9
Sep.  2022
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  CHINESE JOURNAL OF BURNS AND WOUNDS  > 2022  >  38(9): 874-877
Lin WP,Mu X,Chen SH,et al.Clinical characteristics of 11 patients with Vibrio vulnificus infection and the establishment of a rapid diagnosis procedure for this disease[J].Chin J Burns Wounds,2024,40(3):266-272.DOI: 10.3760/cma.j.cn501225-20230803-00036.
Citation: Chen ZH,Yu B,Ye QF,et al.Research advances on interleukin-6 in hypertrophic scar formation[J].Chin J Burns Wounds,2022,38(9):874-877.DOI: 10.3760/cma.j.cn501120-20210331-00111.
shu

Research advances on interleukin-6 in hypertrophic scar formation

doi: 10.3760/cma.j.cn501120-20210331-00111

  • Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan 430071, China

Funds:

Science and Technology Innovation Cultivation Fund of Zhongnan Hospital of Wuhan University znpy2019083

More Information
    Abstract
  • Hypertrophic scar is a pathological repair result of excessive accumulation of extracellular matrix after skin damage, which affects the appearance and function of patients with varying degrees. The degree of scar formation is directly related to the strength of inflammatory reaction during wound healing, and excessive or prolonged inflammatory response increases the incidence of hypertrophic scars. Interleukin-6 (IL-6) is a pleiotropic cytokine that is involved in regulating the fibrotic network composed of fibroblasts, macrophages, keratinocytes, and vascular endothelial cells, and is closely related to the formation of hypertrophic scars. This article reviews the role of IL-6 and its signaling pathway in hypertrophic scar formation.

     

    • FullText(HTML)
    • References(37)
  • [1]
    岑瑛, 刘睿奇. 瘢痕的研究新进展及临床治疗[J].中华烧伤杂志,2019,35(12):839-841. DOI: 10.3760/cma.j.issn.1009-2587.2019.12.002.
    [2]
    WilgusTA. Inflammation as an orchestrator of cutaneous scar formation: a review of the literature[J]. Plast Aesthet Res, 2020,7:54.DOI: 10.20517/2347-9264.2020.150.
    [3]
    TanJ, WuJ. Current progress in understanding the molecular pathogenesis of burn scar contracture[J/OL]. Burns Trauma, 2017,5:14[2022-04-12]. https://pubmed.ncbi.nlm.nih.gov/28546987/.DOI: 10.1186/s41038-017-0080-1.
    [4]
    OgawaR, AkitaS, AkaishiS, et al. Diagnosis and treatment of keloids and hypertrophic scars-Japan Scar Workshop Consensus Document 2018[J/OL]. Burns Trauma, 2019,7:39[2022-04-12]. https://pubmed.ncbi.nlm.nih.gov/31890718/. DOI: 10.1186/s41038-019-0175-y.
    [5]
    ChippE, CharlesL, ThomasC, et al. A prospective study of time to healing and hypertrophic scarring in paediatric burns: every day counts[J/OL]. Burns Trauma, 2017,5:3[2022-04-12]. https://pubmed.ncbi.nlm.nih.gov/28116323/. DOI: 10.1186/s41038-016-0068-2.
    [6]
    van ZuijlenPP, RuurdaJJ, van VeenHA, et al. Collagen morphology in human skin and scar tissue: no adaptations in response to mechanical loading at joints[J]. Burns, 2003,29(5):423-431. DOI: 10.1016/s0305-4179(03)00052-4.
    [7]
    WongVW, PaternoJ, SorkinM, et al. Mechanical force prolongs acute inflammation via T-cell-dependent pathways during scar formation[J]. FASEB J, 2011,25(12):4498-4510. DOI: 10.1096/fj.10-178087.
    [8]
    ShiJ, ShiS, XieW, et al. IL-10 alleviates lipopolysaccharide- induced skin scarring via IL-10R/STAT3 axis regulating TLR4/NF-κB pathway in dermal fibroblasts[J]. J Cell Mol Med, 2021,25(3):1554-1567. DOI: 10.1111/jcmm.16250.
    [9]
    ShiJ, ShiS, XieW, et al. IL-10 alleviates lipopolysaccharide- induced skin scarring via IL-10R/STAT3 axis regulating TLR4/NF-κB pathway in dermal fibroblasts[J]. J Cell Mol Med, 2021, 25(3):1554-1567. DOI: 10.1111/jcmm.16250.
    [10]
    QianLW, FourcaudotAB, YamaneK, et al. Exacerbated and prolonged inflammation impairs wound healing and increases scarring[J]. Wound Repair Regen, 2016,24(1):26-34. DOI: 10.1111/wrr.12381.
    [11]
    DongX, MaoS, WenH. Upregulation of proinflammatory genes in skin lesions may be the cause of keloid formation (Review)[J]. Biomed Rep, 2013,1(6):833-836. DOI: 10.3892/br.2013.169.
    [12]
    BermanB, MaderalA, RaphaelB. Keloids and hypertrophic scars: pathophysiology, classification, and treatment[J]. Dermatol Surg, 2017,43 Suppl 1:S3-18. DOI: 10.1097/DSS.0000000000000819.
    [13]
    李丽, 王林. 正常皮肤与病理性瘢痕组织中HIF-1α和促炎细胞因子水平比较及两者相关性研究[J].中国美容医学,2019,28(4):71-73.
    [14]
    LiechtyKW, AdzickNS, CrombleholmeTM. Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair[J]. Cytokine, 2000,12(6):671-676. DOI: 10.1006/cyto.1999.0598.
    [15]
    刘娜, 张川, 杨磊, 等. 白细胞介素-6单克隆抗体抑制机械张力诱发小鼠增生性瘢痕[J].中华实验外科杂志,2017,34(12):2090-2092. DOI: 10.3760/cma.j.issn.1001-9030.2017.12.024.
    [16]
    HuangJ, ChenJ, WoY, et al. CO2 fractional laser combined with 5-fluorouracil ethosomal gel treatment of hypertrophic scar macro-, microscopic, and molecular mechanism of action in a rabbit animal model[J]. Rejuvenation Res, 2021,24(2):131-138. DOI: 10.1089/rej.2019.2204.
    [17]
    MurakamiM, KamimuraD, HiranoT. Pleiotropy and specificity: insights from the interleukin 6 family of cytokines[J]. Immunity, 2019,50(4):812-831. DOI: 10.1016/j.immuni.2019.03.027.
    [18]
    NaseemS, HussainT, ManzoorS. Interleukin-6: a promising cytokine to support liver regeneration and adaptive immunity in liver pathologies[J]. Cytokine Growth Factor Rev, 2018,39:36-45. DOI: 10.1016/j.cytogfr.2018.01.002.
    [19]
    SchumacherN, Rose-JohnS. ADAM17 activity and IL-6 trans-signaling in inflammation and cancer[J]. Cancers (Basel), 2019, 11(11):1736.DOI: 10.3390/cancers11111736.
    [20]
    LokauJ, AgtheM, FlynnCM, et al. Proteolytic control of interleukin-11 and interleukin-6 biology[J]. Biochim Biophys Acta Mol Cell Res, 2017,1864(11 Pt B):2105-2117. DOI: 10.1016/j.bbamcr.2017.06.008.
    [21]
    KaurS, BansalY, KumarR, et al. A panoramic review of IL-6: structure, pathophysiological roles and inhibitors[J]. Bioorg Med Chem, 2020,28(5):115327. DOI: 10.1016/j.bmc.2020.115327.
    [22]
    ChenW, YuanH, CaoW, et al. Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation[J]. Theranostics, 2019,9(14):3980-3991. DOI: 10.7150/thno.32352.
    [23]
    Epstein ShochetG, BrookE, Bardenstein-WaldB, et al. TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans- signaling[J]. Respir Res, 2020,21(1):56. DOI: 10.1186/s12931-020-1319-0.
    [24]
    HeinkS, YogevN, GarbersC, et al. Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells[J]. Nat Immunol, 2017,18(1):74-85. DOI: 10.1038/ni.3632.
    [25]
    JonesSA, JenkinsBJ. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer[J]. Nat Rev Immunol, 2018,18(12):773-789. DOI: 10.1038/s41577-018-0066-7.
    [26]
    JohnsonBZ, StevensonAW, PrêleCM, et al. The role of IL-6 in skin fibrosis and cutaneous wound healing[J]. Biomedicines, 2020, 8(5):101.DOI: 10.3390/biomedicines8050101.
    [27]
    ČomaM, FröhlichováL, UrbanL, et al. Molecular changes underlying hypertrophic scarring following burns involve specific deregulations at all wound healing stages (inflammation, proliferation and maturation)[J]. Int J Mol Sci, 2021,22(2):897.DOI: 10.3390/ijms22020897.
    [28]
    HasegawaM, SatoS, IhnH, et al. Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis[J]. Rheumatology (Oxford), 1999,38(7):612-617. DOI: 10.1093/rheumatology/38.7.612.
    [29]
    RayS, JuX, SunH, et al. The IL-6 trans-signaling-STAT3 pathway mediates ECM and cellular proliferation in fibroblasts from hypertrophic scar[J]. J Invest Dermatol, 2013,133(5):1212-1220. DOI: 10.1038/jid.2012.499.
    [30]
    DufourAM, AlvarezM, RussoB, et al. Interleukin-6 and type-I collagen production by systemic sclerosis fibroblasts are differentially regulated by interleukin-17A in the presence of transforming growth factor-beta 1[J]. Front Immunol, 2018,9:1865. DOI: 10.3389/fimmu.2018.01865.
    [31]
    Shapouri-MoghaddamA, MohammadianS, VaziniH, et al. Macrophage plasticity, polarization, and function in health and disease[J]. J Cell Physiol, 2018,233(9):6425-6440. DOI: 10.1002/jcp.26429.
    [32]
    XuX, GuS, HuangX, et al. The role of macrophages in the formation of hypertrophic scars and keloids[J/OL]. Burns Trauma, 2020,8:tkaa006[2022-05-07]. https://pubmed.ncbi.nlm.nih.gov/32341919/.DOI: 10.1093/burnst/taa006.
    [33]
    BrauneJ, WeyerU, HobuschC, et al. IL-6 regulates M2 polarization and local proliferation of adipose tissue macrophages in obesity[J]. J Immunol, 2017,198(7):2927-2934. DOI: 10.4049/jimmunol.1600476.
    [34]
    WernerS, KriegT, SmolaH. Keratinocyte-fibroblast interactions in wound healing[J]. J Invest Dermatol, 2007,127(5):998-1008. DOI: 10.1038/sj.jid.5700786.
    [35]
    PengY, WuS, TangQ, et al. KGF-1 accelerates wound contraction through the TGF-β1/Smad signaling pathway in a double-paracrine manner[J]. J Biol Chem, 2019,294(21):8361-8370. DOI: 10.1074/jbc.RA118.006189.
    [36]
    ZhuM, YangM, YangQ, et al. Chronic hypoxia-induced microvessel proliferation and basal membrane degradation in the bone marrow of rats regulated through the IL-6/JAK2/STAT3/MMP-9 pathway[J]. Biomed Res Int, 2020,2020:9204708. DOI: 10.1155/2020/9204708.
    [37]
    LinZQ, KondoT, IshidaY, et al. Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice[J]. J Leukoc Biol, 2003,73(6):713-721. DOI: 10.1189/jlb.0802397.
    • Relative Articles

  • Relative Articles

    [1]Expert consensus on the treatment of second-degree burn wounds (2024 edition) Ⅱ: surgical treatment and infection prevention and treatment[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2024, 40(2): 101-118. doi: 10.3760/cma.j.cn501225-20240112-00015
    [2]Zhu Shaoban, Li Dehui, Liu Da'en, Wei Jun, Zhong Chaoyi, Wu Yajun, Nong Qingwen, Qiu Shumei, Li Shuntang. Analysis of clinical characteristics and treatment of patients with perianal necrotizing fasciitis[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2024, 40(10): 955-962. doi: 10.3760/cma.j.cn501225-20231028-00143
    [3]He Ting, Liu Wei, Shen Chuan'an. Research advances on application of pancreatic stone protein in the early diagnosis of sepsis[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2023, 39(10): 985-988. doi: 10.3760/cma.j.cn501225-20221120-00498
    [4]Luo Gaoxing, Zhan Rixing, Yuan Zhiqiang, Peng Yizhi. Discussion on classification and diagnostic nomenclature of burn infection[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2023, 39(4): 301-304. doi: 10.3760/cma.j.cn501225-20221206-00528
    [5]Zhang Wei, Chen Lan, Yang Fei, Zhang Weidong, Liu Feng, Xie Weiguo. Treatment methods of upper limbs with destructive electric burns and its clinical efficacy[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2023, 39(8): 731-737. doi: 10.3760/cma.j.cn501225-20230530-00188
    [6]Yang Sisi, Zhao Yuanyu, Luo Zhenjin, He Chong, Li Yunheng. Clinical characteristics and analysis of risk factors for heart injuries in 55 patients with lightning injury on plateau in Tibet Autonomous Region[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2023, 39(10): 968-976. doi: 10.3760/cma.j.cn501225-20230413-00124
    [7]Cheng Dasheng, Ji Shizhao, Wang Guangyi, Zhu Feng, Xiao Shichu, Zhu Shihui. Two cases of Vibrio vulnificus primary sepsis[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2022, 38(3): 276-280. doi: 10.3760/cma.j.cn501120-20201027-00448
    [8]Yao Yongming, Luan Yingyi. New understanding on the immunity for severe infections and complications in burns and trauma[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2021, 37(6): 519-523. doi: 10.3760/cma.j.cn501120-20210118-00025
    [9]Zhang Cheng, Peng Yuan, Luo Xiaoqiang, Li Qimeng, Yang Zichen, Chen Yu, Peng Yizhi, Zhang Yixin, Gong Yali. Epidemiological investigation and analysis of etiological characteristics of infection on 3 067 hospitalized pediatric patients with burns[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2021, 37(6): 538-545. doi: 10.3760/cma.j.cn501120-20210201-00044
    [10]Li Min, Zeng Xiangchun, Xie Weiguo. Clinical characteristics of treadmill abrasion in children[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2020, 36(10): 966-968. doi: 10.3760/cma.j.cn501120-20191022-00408
    [11]Zhang Cheng, Gong Yali, Luo Xiaoqiang, Liu Meixi, Shi Yunlong, Liu Tengfei, Li Hangyu, Peng Yizhi. Analysis of the pathogenic characteristics of fungal bloodstream infection in severe burn patients[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2020, 36(1): 37-41. doi: 10.3760/cma.j.issn.1009-2587.2020.01.007
    [12]Gong Yali, Shi Yunlong, Luo Xiaoqiang, Zhang Cheng, Liu Meixi, Chen Yu, Peng Yizhi. Work flow of clinical microbiology laboratory in the epidemic of the coronavirus disease 2019[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2020, 36(7): 579-581. doi: 10.3760/cma.j.cn501120-20200303-00117
    [13]Zhang Wei, Xie Weiguo, Yang Fei, Zhang Weidong, Chen Lan. Clinical application of lobulated transplantation of free anterolateral thigh perforator flap in the treatment of electric burns of limbs[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2019, 35(11): 790-797. doi: 10.3760/cma.j.issn.1009-2587.2019.11.005
    [14]Tian Pengfei, Wang Xin′gang, Zhang Yuanhai, Zhang Jianfen, Xu Bin, Hu Zuliang, Ye Chunjiang, Han Chunmao. Analysis on clinical characteristics of 316 patients with hydrofluoric acid burns[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2018, 34(5): 271-276. doi: 10.3760/cma.j.issn.1009-2587.2018.05.004
    [15]Cheng Lin, Gong Yali, Luo Xiaoqiang, Zhang Cheng, Liu Meixi, Peng Yizhi. Clinical characteristics of burn patients infected with Stenotrophomonas maltophilia and antibiotic resistance of the strains[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2018, 34(2): 78-82. doi: 10.3760/cma.j.issn.1009-2587.2018.02.004
    [16]Liu Shenglan, Sun Xue, Xu Hua, Zhao Daguo, Yang Xinjing, Jin Jun, Wang Jun, Fu Jianhong, Guo Guanghua, Guo Qiang. Analysis on clinical characteristics of 13 extremely severe burn patients complicated with severe inhalation injury in August 2nd Kunshan factory aluminum dust explosion accident[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2018, 34(7): 450-454. doi: 10.3760/cma.j.issn.1009-2587.2018.07.006
    • Supplements(0)
    • Cited By
  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-040200400600800
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 10.3 %FULLTEXT: 10.3 %META: 86.5 %META: 86.5 %PDF: 3.2 %PDF: 3.2 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 4.2 %其他: 4.2 %其他: 0.6 %其他: 0.6 %Kansas City: 0.1 %Kansas City: 0.1 %三亚: 0.1 %三亚: 0.1 %三门峡: 0.3 %三门峡: 0.3 %上海: 1.5 %上海: 1.5 %亳州: 0.3 %亳州: 0.3 %佛山: 0.6 %佛山: 0.6 %佳木斯: 0.4 %佳木斯: 0.4 %保定: 0.1 %保定: 0.1 %信阳: 0.5 %信阳: 0.5 %内湖省: 0.4 %内湖省: 0.4 %包头: 1.2 %包头: 1.2 %北京: 2.7 %北京: 2.7 %十堰: 0.1 %十堰: 0.1 %南京: 1.5 %南京: 1.5 %南宁: 0.3 %南宁: 0.3 %南平: 0.1 %南平: 0.1 %南昌: 0.2 %南昌: 0.2 %南通: 0.1 %南通: 0.1 %南阳: 0.7 %南阳: 0.7 %吉林: 3.1 %吉林: 3.1 %呼伦贝尔: 0.1 %呼伦贝尔: 0.1 %哈尔滨: 0.1 %哈尔滨: 0.1 %哥伦布: 0.3 %哥伦布: 0.3 %唐山: 0.1 %唐山: 0.1 %商丘: 0.3 %商丘: 0.3 %嘉兴: 1.6 %嘉兴: 1.6 %大庆: 0.3 %大庆: 0.3 %天津: 2.0 %天津: 2.0 %安康: 0.4 %安康: 0.4 %宜宾: 0.1 %宜宾: 0.1 %宣城: 0.5 %宣城: 0.5 %宿迁: 0.2 %宿迁: 0.2 %山景城: 0.1 %山景城: 0.1 %常德: 0.1 %常德: 0.1 %广元: 0.5 %广元: 0.5 %广州: 11.8 %广州: 11.8 %廊坊: 0.1 %廊坊: 0.1 %张家口: 1.7 %张家口: 1.7 %徐州: 1.4 %徐州: 1.4 %德州: 0.2 %德州: 0.2 %成都: 0.8 %成都: 0.8 %扬州: 2.0 %扬州: 2.0 %斯特灵: 0.1 %斯特灵: 0.1 %无锡: 0.9 %无锡: 0.9 %昆明: 1.9 %昆明: 1.9 %朝阳: 0.2 %朝阳: 0.2 %杭州: 1.2 %杭州: 1.2 %桂林: 0.2 %桂林: 0.2 %梧州: 0.2 %梧州: 0.2 %榆林: 0.7 %榆林: 0.7 %武汉: 0.3 %武汉: 0.3 %氹仔: 0.2 %氹仔: 0.2 %汕头: 0.2 %汕头: 0.2 %沈阳: 0.7 %沈阳: 0.7 %泰州: 0.4 %泰州: 0.4 %洛阳: 0.7 %洛阳: 0.7 %济南: 1.0 %济南: 1.0 %海得拉巴: 0.3 %海得拉巴: 0.3 %淄博: 0.1 %淄博: 0.1 %淮北: 0.5 %淮北: 0.5 %深圳: 0.3 %深圳: 0.3 %温州: 1.2 %温州: 1.2 %渭南: 0.4 %渭南: 0.4 %湖州: 2.0 %湖州: 2.0 %湛江: 1.2 %湛江: 1.2 %漯河: 2.2 %漯河: 2.2 %漳州: 0.6 %漳州: 0.6 %潍坊: 2.3 %潍坊: 2.3 %潮州: 0.4 %潮州: 0.4 %澳门: 0.5 %澳门: 0.5 %濮阳: 0.3 %濮阳: 0.3 %牡丹江: 0.3 %牡丹江: 0.3 %珠海: 0.1 %珠海: 0.1 %盐城: 0.8 %盐城: 0.8 %盘锦: 0.5 %盘锦: 0.5 %石家庄: 0.8 %石家庄: 0.8 %福州: 0.1 %福州: 0.1 %秦皇岛: 2.4 %秦皇岛: 2.4 %绍兴: 0.6 %绍兴: 0.6 %绥化: 1.3 %绥化: 1.3 %肇庆: 0.2 %肇庆: 0.2 %芒廷维尤: 12.7 %芒廷维尤: 12.7 %苏州: 0.2 %苏州: 0.2 %荆门: 2.0 %荆门: 2.0 %莱芜: 0.2 %莱芜: 0.2 %菏泽: 0.3 %菏泽: 0.3 %蚌埠: 0.2 %蚌埠: 0.2 %西宁: 0.7 %西宁: 0.7 %西安: 0.7 %西安: 0.7 %赣州: 0.2 %赣州: 0.2 %运城: 0.4 %运城: 0.4 %通化: 0.2 %通化: 0.2 %邯郸: 0.3 %邯郸: 0.3 %郑州: 0.2 %郑州: 0.2 %酒泉: 0.1 %酒泉: 0.1 %重庆: 4.7 %重庆: 4.7 %金华: 0.5 %金华: 0.5 %长沙: 2.9 %长沙: 2.9 %阜阳: 0.3 %阜阳: 0.3 %青岛: 0.5 %青岛: 0.5 %马鞍山: 0.1 %马鞍山: 0.1 %鸡西: 0.4 %鸡西: 0.4 %齐齐哈尔: 1.1 %齐齐哈尔: 1.1 %其他其他Kansas City三亚三门峡上海亳州佛山佳木斯保定信阳内湖省包头北京十堰南京南宁南平南昌南通南阳吉林呼伦贝尔哈尔滨哥伦布唐山商丘嘉兴大庆天津安康宜宾宣城宿迁山景城常德广元广州廊坊张家口徐州德州成都扬州斯特灵无锡昆明朝阳杭州桂林梧州榆林武汉氹仔汕头沈阳泰州洛阳济南海得拉巴淄博淮北深圳温州渭南湖州湛江漯河漳州潍坊潮州澳门濮阳牡丹江珠海盐城盘锦石家庄福州秦皇岛绍兴绥化肇庆芒廷维尤苏州荆门莱芜菏泽蚌埠西宁西安赣州运城通化邯郸郑州酒泉重庆金华长沙阜阳青岛马鞍山鸡西齐齐哈尔

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (333) PDF downloads(28) Cited by()
    Proportional views
    Related

    Copyright © Chinese Journal of Burns京ICP备07035254号-14

    E-mail：shaoshangzazhi@163.com

    Website：https://zhsszz.xml-journal.net/

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return